# Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-072)

> **NCT00111722** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 393 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** MK0462, rizatriptan benzoate / Duration of Treatment -1day
- **DRUG:** Comparator: placebo / Duration of Treatment - 1 day

## Key facts

- **NCT ID:** NCT00111722
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05-27
- **Primary completion:** 2006-02-15
- **Final completion:** 2006-02-23
- **Target enrollment:** 393 (ACTUAL)
- **Last updated:** 2024-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00111722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00111722, "Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-072)". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00111722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*